PGIM Jennison Health Sciences Fund- Class C
PHLCX
NASDAQ
Weiss Ratings | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C+ | |||
Risk Index | Fair | |||
Risk Grade | C- | |||
Company Info | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | PGIM Investments | |||
Manager/Tenure (Years) | Debra Netschert (10), Daniel Matviyenko (4) | |||
Website | http://www.prudentialfunds.com | |||
Fund Information | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | PGIM Jennison Health Sciences Fund- Class C | |||
Category | Health | |||
Sub-Category | Healthcare Sector Equity | |||
Prospectus Objective | Specialty - Health | |||
Inception Date | Jun 30, 1999 | |||
Open/Closed To New Investors | Closed | |||
Minimum Initial Investment | 1,000.00 | |||
Minimum Subsequent Investment | 100.00 | |||
Front End Fee | -- | |||
Back End Fee | 0.01 | |||
Dividends and Shares | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 1.39% | |||
Dividend | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 0.62% | |||
Asset Allocation | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 3.95% | |||
Stock | 96.06% | |||
U.S. Stock | 83.03% | |||
Non-U.S. Stock | 13.03% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | 0.00% | |||
Price History | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.56% | |||
30-Day Total Return | 1.81% | |||
60-Day Total Return | 5.66% | |||
90-Day Total Return | 6.12% | |||
Year to Date Total Return | -1.59% | |||
1-Year Total Return | -10.40% | |||
2-Year Total Return | 13.60% | |||
3-Year Total Return | 27.92% | |||
5-Year Total Return | 27.88% | |||
Price | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $12.31 | |||
1-Month Low NAV | $12.05 | |||
1-Month High NAV | $12.58 | |||
52-Week Low NAV | $10.87 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $19.48 | |||
52-Week High Price (Date) | Sep 20, 2024 | |||
Beta / Standard Deviation | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.55 | |||
Standard Deviation | 13.74 | |||
Balance Sheet | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 1.34B | |||
Operating Ratios | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 1.96% | |||
Turnover Ratio | 79.00% | |||
Performance | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 7.98% | |||
Last Bear Market Total Return | -9.62% | |||